Sapna Srivastava
CIK 1569226 · last filed 2025-10-28
Sapna Srivastava is a corporate insider who has filed 30 SEC Form 4 insider transactions across 8 companies since 2015. The most recent filing, for TRML, was dated Oct 28, 2025. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.79M
8
30
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tourmaline Bio, Inc. (TRML) Delisted | Director | 0 | $47.98 | $0 | $0 | 3 | 2025-10-28 |
| ALMS | Director | — | $24.15 | — | $0 | 2 | 2025-08-01 |
| NUVL | Director | 5,146 | $123.25 | $634.2K | $0 | 5 | 2025-06-20 |
| AURA | Director | 23,500 | $6.41 | $150.6K | $0 | 5 | 2025-06-18 |
| INVA | Director | 44,096 | $22.74 | $1.00M | $0 | 2 | 2024-06-20 |
| SQZ Biotechnologies Co (SQZ) Delisted | Director | — | $0.43 | — | $0 | 4 | 2023-06-15 |
| Tourmaline Bio, Inc. (TALS) Delisted | Director | — | $27.20 | — | $0 | 2 | 2023-06-14 |
| MedAvail Holdings, Inc. (MYOS) Delisted | Director | — | — | — | $0 | 1 | 2015-01-12 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-28 | Tourmaline Bio, Inc. (TRML) Delisted | Mixed | −518 | $0 | EDGAR |
| 2025-08-01 | ALMS | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | NUVL | Grant (A) | +2,647 | $0 | EDGAR |
| 2025-06-18 | AURA | Grant (A) | +13,000 | $0 | EDGAR |
| 2025-06-06 | Tourmaline Bio, Inc. (TRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | ALMS | Mixed | — | $0 | EDGAR |
| 2024-06-24 | AURA | Grant (A) | +10,500 | $0 | EDGAR |
| 2024-06-20 | INVA | Grant (A) | +13,923 | $0 | EDGAR |
| 2024-06-14 | NUVL | Grant (A) | +2,499 | $0 | EDGAR |
| 2024-06-07 | Tourmaline Bio, Inc. (TRML) Delisted | Grant (A) | — | $0 | EDGAR |